Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Potential future neuroprotective therapies for neurodegenerative disorders and stroke Tarawneh R; Galvin JEClin Geriatr Med 2010[Feb]; 26 (1): 125-47The cellular mechanisms underlying neuronal loss and neurodegeneration have been an area of interest in the last decade. Although neurodegenerative diseases such as Alzheimer disease, Parkinson disease, and Huntington disease each have distinct clinical symptoms and pathologies, they all share common mechanisms such as protein aggregation, oxidative injury, inflammation, apoptosis, and mitochondrial injury that contribute to neuronal loss. Although cerebrovascular disease has different causes from the neurodegenerative disorders, many of the same common disease mechanisms come into play following a stroke. Novel therapies that target each of these mechanisms may be effective in decreasing the risk of disease, abating symptoms, or slowing down their progression. Although most of these therapies are experimental, and require further investigation, a few seem to offer promise.|Humans[MESH]|Inflammation Mediators/physiology[MESH]|Mitochondrial Diseases/complications/pathology/physiopathology[MESH]|Neurodegenerative Diseases/*etiology/metabolism/*prevention & control[MESH]|Neuroprotective Agents/therapeutic use[MESH]|Oxidative Stress/physiology[MESH]|Protein Binding/physiology[MESH]|Protein Folding[MESH]|Receptors, N-Methyl-D-Aspartate/physiology[MESH]|Stroke/*etiology/metabolism/*prevention & control[MESH] |